Categories: Research

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

Update from the Dean: Building community while staying safe

Our COVID-19 response: As we return to campus, everyone’s well-being is our top concern. But we also need to consider the need to maintain and strengthen community.

In clinical work and discovery science, the School takes on COVID-19

The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.

Update from the Dean: Eyeing a return

Our COVID-19 response: Dean Guglielmo provides an update on School activities and a careful return to campus

Overcoming disease with moving pictures and molecular building blocks

Jaime Fraser delivered the 2020 Byers Award Lecture in Basic Science

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

QBI Coronavirus Research Group races toward a cure

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Pages